Detection of cytomegalovirus late (pp150) antigen in peripheral blood leukocytes of patients with human immunodeficiency virus-related lymphoma.
暂无分享，去创建一个
[1] G. Weverling,et al. Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients. , 1999, AIDS.
[2] B. Hofmann,et al. Development of cytomegalovirus (CMV) disease may be predicted in HIV‐infected patients by CMV polymerase chain reaction and the antigenemia test , 1997, AIDS.
[3] F. Hufert,et al. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients. , 1995, The Journal of infectious diseases.
[4] A. Bitsch,et al. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. , 1993, The Journal of infectious diseases.
[5] G. Gerna,et al. Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients. , 1993, Clinical and diagnostic virology.
[6] G. Gerna,et al. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia , 1992, Journal of clinical microbiology.